Life Sciences & Health Consortium

Obtaining competitive intelligence is a vital part of any business, and especially for life science companies. Having access to the latest information on patents, developmental status of a comparative product, design and outcome of clinical trials and licensing deals done is a valuable asset, but often comes at a high price.

To provide access to this kind of information at an affordable price and allow companies to use this to bring their innovations faster to market, Life Sciences & Health has discussed the initiation of a consortium with Thomson Reuters for access to their pharmaceutical database, Thomson Pharma.

Under this consortium agreement Dutch small-to-medium sized companies and institutes can get access to their database at a substantially reduced rate.

Exclusively through the consortium agreement, you can request for a free trial to Thomson Pharma to assess the usefulness of this resource.

For more details on joining the consortium or requesting a trial period, fill out this form.

Thomson Pharma® is a comprehensive global pharmaceutical information solution that covers the entire drug discovery and development pipeline, giving you the freedom to explore the best pharmaceutical content from extensive collection of scientific, healthcare and financial information databases offered by Thomson Reuters.

Thomson Pharma’s competitive intelligence and strategic data can justify and speed your decision-making, facilitate more focused collaboration, and encourage innovation. No other data source puts so much information at your fingertips.

Learn more at the Thompson Reuters Pharma website